Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection - PubMed (original) (raw)
doi: 10.1002/hep.510250342.
A Tsubota, M Kobayashi, K Okamoto, M Hashimoto, Y Miyano, H Koike, M Kobayashi, I Koida, Y Arase, S Saitoh, Y Suzuki, N Murashima, K Ikeda, H Kumada
Affiliations
- PMID: 9049229
- DOI: 10.1002/hep.510250342
Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection
K Chayama et al. Hepatology. 1997 Mar.
Abstract
Hepatitis C virus (HCV) genotype 1b and high pretreatment virus load are predictive factors of poor response to interferon therapy in patients with chronic hepatitis C. To further examine the factors predicting the response to interferon in patients with genotype 1b infection, we analyzed 110 consecutive patients with HCV who were treated with a total of 624 million units of lymphoblastoid interferon alfa. Thirty-six patients (33%) were responders, while the remaining 74 patients (67%) were nonresponders. Multivariate analysis showed that a high virus titer (assessed by serum core protein level, P = .0021) and the presence of more than two amino acid substitutions in the interferon sensitivity-determining region (ISDR) (P = .0036) correlated significantly with the response to interferon therapy. Because mutations analyzed by direct sequencing of polymerase chain reaction (PCR) products may reflect artifacts of direct sequencing, we further analyzed quasispecies of HCV in this region by cloning and sequencing. Although PCR-based analysis of responders with multiple amino acid substitutions in the ISDR showed the presence of a small amount of wild-type strain in their serum, the results obtained by direct sequencing and cloning were essentially the same. A longitudinal study of quasispecies in 2 patients who showed a dramatic change in the virus titer showed no conversion from wild type to mutant or vice versa. Our results indicate that amino acid substitutions and virus load are independent predictors of the response to interferon therapy. The ability of some patients with no mutation in the ISDR or high virus load to eliminate the virus suggests the presence of other unidentified factors, host or viral, that influence the response to interferon therapy.
Comment in
- The interferon sensitivity determining region: all hepatitis C virus isolates are not the same.
Herion D, Hoofnagle JH. Herion D, et al. Hepatology. 1997 Mar;25(3):769-71. doi: 10.1002/hep.510250346. Hepatology. 1997. PMID: 9049233 No abstract available.
Similar articles
- Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa.
Zeuzem S, Lee JH, Roth WK. Zeuzem S, et al. Hepatology. 1997 Mar;25(3):740-4. doi: 10.1002/hep.510250341. Hepatology. 1997. PMID: 9049228 - Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection.
Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F, Sato C. Enomoto N, et al. N Engl J Med. 1996 Jan 11;334(2):77-81. doi: 10.1056/NEJM199601113340203. N Engl J Med. 1996. PMID: 8531962 - Association of amino acid sequence in the PKR-eIF2 phosphorylation homology domain and response to interferon therapy.
Chayama K, Suzuki F, Tsubota A, Kobayashi M, Arase Y, Saitoh S, Suzuki Y, Murashima N, Ikeda K, Takahashi N, Kinoshita M, Kumada H. Chayama K, et al. Hepatology. 2000 Nov;32(5):1138-44. doi: 10.1053/jhep.2000.19364. Hepatology. 2000. PMID: 11050067 - Hepatitis C virus: How genetic variability affects pathobiology of disease.
Chayama K, Hayes CN. Chayama K, et al. J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:83-95. doi: 10.1111/j.1440-1746.2010.06550.x. J Gastroenterol Hepatol. 2011. PMID: 21199518 Review. - [Fluctuation of hepatitis C virus quasispecies with interferon treatment and interferon-resistant variants in hepatitis C virus 1b].
Sakuma I, Enomoto N, Asahina Y, Kurosaki M, Sato C. Sakuma I, et al. Nihon Rinsho. 1995 Sep;53 Suppl(Pt 1):930-5. Nihon Rinsho. 1995. PMID: 7563904 Review. Japanese. No abstract available.
Cited by
- Interferon sensitivity-determining region of hepatitis C virus influences virus production and interferon signaling.
Sugiyama R, Murayama A, Nitta S, Yamada N, Tasaka-Fujita M, Masaki T, Aly HH, Shiina M, Ryo A, Ishii K, Wakita T, Kato T. Sugiyama R, et al. Oncotarget. 2017 Dec 21;9(5):5627-5640. doi: 10.18632/oncotarget.23562. eCollection 2018 Jan 19. Oncotarget. 2017. PMID: 29464023 Free PMC article. - Hepatitis C virus NS5A region mutation in chronic hepatitis C genotype 1 patients who are non-responders to two or more treatments and its relationship with response to a new treatment.
Muñoz de Rueda P, Fuentes Rodríguez JM, Quiles Pérez R, Gila Medina A, Martín Álvarez AB, Casado Ruíz J, Ruíz Extremera A, Salmerón J. Muñoz de Rueda P, et al. World J Gastroenterol. 2017 Jul 7;23(25):4538-4547. doi: 10.3748/wjg.v23.i25.4538. World J Gastroenterol. 2017. PMID: 28740342 Free PMC article. - The role of HCV proteins on treatment outcomes.
Kumthip K, Maneekarn N. Kumthip K, et al. Virol J. 2015 Dec 15;12:217. doi: 10.1186/s12985-015-0450-x. Virol J. 2015. PMID: 26666318 Free PMC article. Review. - Clinical utility of pharmacogenomics in the management of hepatitis C.
Trinks J, Hulaniuk ML, Redal MA, Flichman D. Trinks J, et al. Pharmgenomics Pers Med. 2014 Oct 20;7:339-47. doi: 10.2147/PGPM.S52624. eCollection 2014. Pharmgenomics Pers Med. 2014. PMID: 25382982 Free PMC article. Review. - Impact of hepatitis C virus heterogeneity on interferon sensitivity: an overview.
El-Shamy A, Hotta H. El-Shamy A, et al. World J Gastroenterol. 2014 Jun 28;20(24):7555-69. doi: 10.3748/wjg.v20.i24.7555. World J Gastroenterol. 2014. PMID: 24976696 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical